Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
183,255,226
-
Total 13F shares
-
62,400,860
-
Share change
-
+19,823,038
-
Total reported value
-
$936,042,765
-
Put/Call ratio
-
117%
-
Price per share
-
$15.00
-
Number of holders
-
93
-
Value change
-
+$300,270,140
-
Number of buys
-
70
-
Number of sells
-
25
Institutional Holders of HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (HRTX) as of Q1 2017
As of 31 Mar 2017,
HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (HRTX) was held by
93 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
62,400,860 shares.
The largest 10 holders included
FRANKLIN RESOURCES INC, FMR LLC, JANUS CAPITAL MANAGEMENT LLC, Broadfin Capital, LLC, Partner Fund Management, L.P., Invesco Ltd., BAKER BROS. ADVISORS LP, BlackRock Inc., KINGDON CAPITAL MANAGEMENT, L.L.C., and CARLSON CAPITAL L P.
This page lists
93
institutional shareholders reporting positions in this security
for the Q1 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.